1 |
Kwon B: CD137-CD137 ligand interactions in inflammation. Immune Netw 9;84-89, 2009.
DOI
|
2 |
Melero I, Shuford WW, Newby SA, Aruffo A, Ledbetter JA, Hellström KE, Mittler RS, Chen L: Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 3;682-685, 1997.
DOI
ScienceOn
|
3 |
Kwon B: Intervention with costimulatory pathways as a therapeutic approach for graft-versus-host disease. Exp Mol Med 42;675-683, 2010.
DOI
|
4 |
Kim J, Choi WS, La S, Suh JH, Kim BS, Cho HR, Kwon BS, Kwon B: Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells. Blood 105;2206-2213, 2005.
DOI
ScienceOn
|
5 |
Kim J, Kim HJ, Park K, Kim J, Choi HJ, Yagita H, Nam SH, Cho HR, Kwon B: Costimulatory molecule-targeted immunotherapy of cutaneous graft-versus-host disease. Blood 110;776-782, 2007.
DOI
ScienceOn
|
6 |
Zhang B, Maris CH, Foell J, Whitmire J, Niu L, Song J, Kwon BS, Vella AT, Ahmed R, Jacob J, Mittler RS: Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J Clin Invest 117;3029-3041, 2007.
DOI
ScienceOn
|
7 |
Zhang B, Zhang Y, Niu L, Vella AT, Mittler RS: Dendritic cells and Stat3 are essential for CD137-induced CD8 T cell activation-induced cell death. J Immunol 184;4770-4778, 2010.
DOI
ScienceOn
|